HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Schroder Investment Management Group

Schroder Investment Management Group trimmed its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 0.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 697,938 shares of the company's stock after selling 3,060 shares during the period. Schroder Investment Management Group owned about 0.28% of HCA Healthcare worth $208,279,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently modified their holdings of the company. Whipplewood Advisors LLC purchased a new stake in shares of HCA Healthcare in the 4th quarter worth $31,000. Tidemark LLC purchased a new position in HCA Healthcare during the 4th quarter valued at about $36,000. Legacy Investment Solutions LLC purchased a new stake in shares of HCA Healthcare in the 3rd quarter worth approximately $39,000. Activest Wealth Management raised its stake in HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company's stock worth $40,000 after buying an additional 125 shares in the last quarter. Finally, Pinnacle Bancorp Inc. boosted its position in HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock valued at $45,000 after purchasing an additional 50 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock traded up $4.17 on Thursday, reaching $351.20. The company's stock had a trading volume of 694,306 shares, compared to its average volume of 1,347,297. The stock has a 50-day moving average price of $326.35 and a 200-day moving average price of $340.30. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The company has a market capitalization of $86.47 billion, a P/E ratio of 15.99, a PEG ratio of 1.10 and a beta of 1.68. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07.

Remove Ads

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the company earned $5.90 earnings per share. Analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.82%. The ex-dividend date was Monday, March 17th. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. HCA Healthcare's payout ratio is 13.11%.

Wall Street Analyst Weigh In

HCA has been the topic of several analyst reports. Royal Bank of Canada cut their price target on shares of HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating on the stock in a report on Monday, January 27th. Truist Financial decreased their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Bank of America decreased their price target on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a report on Monday, January 27th. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $380.00 target price on shares of HCA Healthcare in a research report on Tuesday, December 17th. Finally, Barclays cut their price objective on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $385.67.

Insider Activity

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the firm's stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares of the company's stock, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 1.30% of the company's stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.